The fund invests in health care companies worldwide. This includes companies carrying out their business activity in the following industries: health care equipment and services, research, development, production or marketing of pharmaceuticals or biotechnology products. The portfolio is diversified across different countries. Measured over a period of several years we aim to beat the performance of the benchmark MSCI World Health Care NR. We strive to add value to the fund by stock selection based on a thorough company analysis. We consciously weigh the upside potential from the current share price against the risks involved, before including a stock in the fund.